PREDICTIVE TECHNOLOGY GROUP, INC. (OTCMKTS:PRED) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

The Board of Directors voted in accordance to the Company’s
Bylaws to change the Company’s operational year-end for August
to June. On June 1, 2017, the Nevada Secretary of State approved
the amended year-end to 06/30 (see exhibit).

Item 9.01.Financial Statements and Exhibits.

(a)Financial statements of business acquired. Not
applicable.

(b)Pro forma financial information. Not applicable.

(c)Shell registrant transactions. Not applicable.

(d)Exhibits.

____________

*Filed herewith.

-2-

About PREDICTIVE TECHNOLOGY GROUP, INC. (OTCMKTS:PRED)

Predictive Technology Group, Inc. is engaged in the business of developing and implementing medical solutions to various aliments, which commonly afflict individuals domestically and around the world. The Company is focused on identifying, developing, acquiring and commercializing medical apparatuses and treatments. Its subsidiaries include Predictive Therapeutics, LLC, LifeCode Genetics, Inc. and Predictive Biotech, Inc. Predictive Therapeutics, LLC revolutionizes the treatment of serious and debilitating diseases through the commercialization of therapeutics leveraged by gene-based companion diagnostics. It uses gene-based information as the cornerstone in the development of diagnostics that assess a person’s risk of disease and therapeutic products designed to prevent and/or treat the disease. LifeCode Genetics, Inc. develops and commercializes gene-based diagnostics. Predictive Biotech, Inc. is in the business of creating treatments utilizing the advancements in cellular biology.